Login / Signup

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Thomas KaragiannisKonstantinos MalandrisIoannis AvgerinosAthina StamatiPanagiota KakotrichiAris LiakosDespoina VasilakouNikolaos KakaletsisApostolos TsapasApostolos Tsapas
Published in: Diabetologia (2024)
PROSPERO registration no. CRD42022382594.
Keyphrases